sources of contamination in pharma - An Overview
In December 2019, Woodcock released a white paper about holding pharmaceutical makers to a high quality management maturity typical to ensure that the US drug offer continues to be safe. At this time, the FDA just issues warnings to brands when they don’t meet specifications, Woodcock says. “We are quite enthusiastic about putting out some form